Two years after trial termination, vitamin D 2000 IU/day's protective effects dissipated, but 1000 mg/day n-3 fatty acids had a sustained effect in reducing AD incidence. To read the full article, choose Open Athens “Institutional Login” and search for “Midlands Partnership”.